Purchase Order 15B30826P00000006
- Not listed
- McKesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a firm fixed-price purchase order valued at $3,500 by the Federal Correctional Institution Marianna, a civilian agency under the Department of Justice's Bureau of Prisons. The contract, awarded on December 1, 2025, covers pharmacy drugs for December fiscal year 2026 and is scheduled for ultimate completion by December 31, 2025. The place of performance is...
- Mckesson Corporation has been awarded a firm fixed price delivery order valued at $139,256.95 by the Department of Justice Bureau of Prisons Federal Correctional Institution Marianna. The delivery order, issued under the contract "DRUGS FOR PHARMACY - JANUARY 2023," provides pharmaceutical products to the correctional facility in Irving, Texas, with performance through August 9, 2024. No set-aside designation was applied to this award. As a leading healthcare services and information...
- Mckesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a delivery order valued at $50,000 for regular drugs to support Federal Correctional Institution Marianna for December 2025. The contract, issued on December 1, 2025, with an ultimate completion date of December 31, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed at Mckesson's facility in...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Marianna awarded McKesson Corporation a $105,478 fixed-price delivery order contract to provide drugs for its pharmacy needs from August through September 2023. McKesson will deliver the pharmaceutical products to the correctional facility located in Irving, Texas. As one of the largest healthcare services companies in the U.S., McKesson has extensive experience supporting correctional healthcare programs through the...
- McKesson Corporation has been awarded a delivery order valued at $89,209.16 for the provision of regular drugs to the Federal Correctional Institution Marianna in October 2025. The contract, awarded on October 1, 2025, with an ultimate completion date of December 8, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is McKesson's Irving, Texas location, and the funding agency is the Federal Correctional Institution Marianna, which...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Marianna awarded McKesson Corporation a $2,684.87 purchase order contract to provide drugs for pharmacy services from October 1, 2023 through November 16, 2023. McKesson will deliver the pharmaceutical products to the correctional facility located in Irving, Texas. The firm fixed price contract was awarded without any set aside designations. McKesson will perform as the prime contractor, with no mention of major...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Marianna awarded McKesson Corporation a $100,000 firm fixed price delivery order contract to provide drugs for pharmacy services from November 2023 through August 2024. McKesson will supply pharmaceutical products to the Bureau of Prisons facility in Irving, Texas under the terms of this order issued against an unspecified governmentwide acquisition contract vehicle. No subcontractors or set aside designations were...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Marianna awarded McKesson Corporation a $3,534.41 purchase order contract to provide drugs for the pharmacy from August 1st through September 8th, 2023. McKesson will deliver the pharmaceutical products to the correctional facility located in Irving, Texas. As the prime contractor, McKesson will be responsible for fulfilling the requirements set forth in the solicitation to supply medications to the Bureau of Prisons...
- Mckesson Corporation received a delivery order award from the Federal Correctional Institution Marianna, a civilian facility under the Department of Justice's Bureau of Prisons, for the provision of regular pharmaceutical drugs for November 2025. This firm fixed price delivery order, issued on November 1, 2025, carries a ceiling value of $50,000 and is scheduled for completion by November 30, 2025. The contract involves no set-aside designation and will be performed at Mckesson's distribution...
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a Firm Fixed Price purchase order valued at $7,338.40 by the Federal Correctional Complex Pollock on November 14, 2025. The contract, designated as Controlled Subs Order PO 3714, represents a non-competed award with an ultimate completion date of November 17, 2025, and will be performed in Irving, Texas. This purchase order falls under the civilian...
McKesson Corporation was awarded a firm fixed-price purchase order valued at $4,378.33 for pharmaceutical products to support the Federal Correctional Institution Marianna in October fiscal year 2026. The award, effective October 1, 2025, with an ultimate completion date of December 8, 2025, represents a modification to add funding to an existing order. No set-aside designation was used in this competitive award. Performance will be executed from McKesson's location in Irving, Texas, where the company maintains its headquarters and primary pharmaceutical distribution operations. The Federal Bureau of Prisons within the Department of Justice funds this purchase order, reflecting McKesson's established role as a primary pharmaceutical supplier to correctional facilities across the federal prison system. As a large business contractor, McKesson supplies controlled and non-controlled medications, medical consumables, and specialty pharmaceuticals to numerous Bureau of Prisons facilities. This award exemplifies the company's consistent engagement in supporting federal correctional healthcare operations and demonstrates its capability to respond rapidly to pharmaceutical procurement needs within the federal prison healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $878 | 12/8/25 |